LigaTrap™ Technologies, LLC
Michael Crapanzano has extensive experience as a founder and managing partner in the healthcare industry. In 1997, they founded Pediatric Cardiology Associates of Louisiana and later went on to establish Pediatric Intensivists of Louisiana and Pediatric Hospitalists of Louisiana in 2003. In 2015, Michael founded LigaTrap™ Technologies, LLC, where they currently serve as the Founder and CEO.
Michael Crapanzano has a Bachelor of Science (BS) degree in Zoology/Animal Biology, which they obtained from Louisiana State University from 1980 to 1984. Michael went on to pursue a Doctor of Medicine (MD) degree at the same university from 1984 to 1988. Following this, Michael completed a Pediatric and Pediatric Cardiology Residency and Fellowship at the Medical College of Georgia at Augusta University between 1988 and 1995. Later, from 2004 to 2006, they attended the Harvard T.H. Chan School of Public Health, where they earned a Master in Health Care Management degree.
This person is not in any teams
This person is not in any offices
LigaTrap™ Technologies, LLC
LigaTrap has developed a novel, patented portfolio of affinity ligands for the purification of monoclonal and polyclonal immunoglobulins from various species. In addition to species-specific ligands, advantages include the ability to elute bound antibodies at a milder pH (pH 4.0) than proteins A and G (pH ≤ 3.0), thus reducing the potential forprecipitation and inactivation of pH sensitive antibodies.Their research lab is in Raleigh, NC and their corporate office is in Baton Rouge, LA, their goal is to generate high purity antibodies using ligands superior to those currently available in the marketplace. Through extensive side-by-side testing with purification products that are currently on the market, beta testing from independent third parties, market research by industry experts, and feedback from leading think tanks within the sector, the technology is proven and deemed superior to those available in specific niche uses.